Efficacy and Safety of Mirikizumab (LY3074828) in the Treatment of Moderate-to-Severe Plaque Psoriasis: Results from a Randomised Phase 2 Study
Reich, K., Rich, P., Maari, C., Bissonnette, R., Leonardi, C., Menter, A., Igarashi, A., Klekotka, P., Patel, D., Li, J., Tuttle, J., Morgan-Cox, M., Edson-Heredia, E., Friedrich, S., Papp, K.Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.17628
Date:
February, 2019
File:
PDF, 384 KB
english, 2019
File converter
More search results
More benefits 
